Peptiva
Semaglutide
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is Semaglutide?
Semaglutide is a long-acting synthetic analog of glucagon-like peptide-1 (GLP-1), a natural incretin hormone involved in glucose regulation and satiety. The extended stability of the molecule has allowed for detailed study of GLP-1 signaling in metabolic models.
Mechanism and Scientific Context
GLP-1 receptor activation enhances glucose-dependent insulin secretion, reduces inappropriate glucagon release, slows gastric emptying, and acts on neural pathways related to appetite. In research, the peripheral and central effects of this mechanism are observed separately.
Main Research Areas
- GLP-1 signaling and glycemic homeostasis
- satiety, eating behavior, and body composition
- lipid profile and cardiometabolic factors
- metabolic changes in the liver and adipose tissue
How to interpret research data?
When reading literature, check the identity of the tested material, the type of model, and the limitations of the study. The existence of a paper on a molecule does not confirm the properties of this product or its batch. Findings from laboratory and animal models do not prove clinical benefit.
Available Peptiva variants
- 2 mg · Lyophilized vial
- 2 mg · Research dispenser
- 5 mg · Lyophilized vial
- 5 mg · Research dispenser
Select an available variant and check its name, total content, and price. The photograph is not a substitute for the declaration of the selected variant.
Packaging format and content
Research dispenser: the variant contains an entire filled dispenser with the selected content, not just a separate replacement cartridge. The quantity stated with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: the variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing precision, stability, or suitability for human or animal application.
Important Limitations
Data on approved medications cannot be directly applied to research material. The Peptiva Peptides product is exclusively for controlled laboratory research.
Batch Documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. Availability and scope of analyses are checked for the specific batch. The COA does not inherently prove sterility or suitability for human or animal application.
Intended use and limitations: The product is intended exclusively for laboratory research. It is not intended for human or animal application, diagnosis, treatment, alleviation, or prevention of disease. The description is not medical advice. The label of research use and the packaging name do not by themselves determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.